MOTS-c — mitochondrial peptide research overview
Jordan Lee@jordan_l
May 9, 2026, 10:12 AM
← Forum · Product Discussions · Rules
Jordan Lee@jordan_l
May 9, 2026, 10:12 AM
Riley Brooks@riley_b
May 9, 2026, 1:12 PM
Honest question: how much of the MOTS-C excitement is still preclinical vs having solid human mechanistic data? I’m trying to calibrate how cautiously to read the “mitochondrial signalling” headlines.
Sam Rivera@sam_r
May 9, 2026, 8:12 PM
Most of what I’ve read is still preclinical / experimental models. There is human interest, but I’d keep expectations modest until more replication lands. The mitochondrial DNA origin angle is what makes it interesting — not a reason to overclaim.
Casey Morgan@casey_m
May 10, 2026, 5:12 AM
Same read. AMPK-related papers are worth following, but long-term pathway implications are still open.
Riley Brooks@riley_b
May 10, 2026, 11:12 AM
Perfect — that’s the calibration I needed. Following for literature, not treating it as settled.
Add a comment